Chen Chiwei, Huang Renlun, Zhou Jianfu, Guo Lang, Xiang Songtao
The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
Front Pharmacol. 2022 Aug 17;13:897942. doi: 10.3389/fphar.2022.897942. eCollection 2022.
Prostate cancer with bone metastasis has a high cancer-specific mortality. Thus, it is essential to delineate the mechanism of bone metastasis. Pre-metastatic niche (PMN) is a concept in tumor metastasis, which is characterized by tumor-secreted factors, reprogramming of stromal cells, and immunosuppression by myeloid-derived suppressor cells (MDSC), which is induced by bone marrow-derived cells (BMDC) in the target organ. However, PMN does not explain the predilection of prostate cancer towards bone metastasis. In this review, we discuss the initiation of bone metastasis of prostate cancer from the perspective of PMN and tumor microenvironment in a step-wise manner. Furthermore, we present a new concept called pre-metastatic bone niche, featuring inherent BMDC, to interpret bone metastasis. Moreover, we illustrate the regulation of traditional Chinese medicine on PMN.
伴有骨转移的前列腺癌具有较高的癌症特异性死亡率。因此,明确骨转移机制至关重要。转移前微环境(PMN)是肿瘤转移中的一个概念,其特征在于肿瘤分泌因子、基质细胞重编程以及骨髓来源细胞(BMDC)在靶器官诱导的髓源性抑制细胞(MDSC)介导的免疫抑制。然而,PMN并不能解释前列腺癌对骨转移的偏好。在本综述中,我们从PMN和肿瘤微环境的角度逐步探讨前列腺癌骨转移的起始。此外,我们提出了一个名为转移前骨微环境的新概念,其特征为固有BMDC,以解释骨转移。此外,我们阐述了中药对PMN的调节作用。